# Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

> **NCT04803734** · NA · COMPLETED · sponsor: **Intech Biopharm Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Albuterol Sulfate inhalation aerosol 108mcg per actuation
- **DRUG:** Proair HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation

## Key facts

- **NCT ID:** NCT04803734
- **Lead sponsor:** Intech Biopharm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-19
- **Primary completion:** 2021-05-10
- **Final completion:** 2021-05-14
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04803734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04803734, "Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04803734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*